AB Science: New independent research reveals that masitinib has direct anti-viral activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating COVID-19 - GlobeNewswire

AB Science: New independent research reveals that masitinib has direct anti-viral activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating COVID-19  GlobeNewswire

Comments

Popular posts from this blog

UConn Health's Caryl Ryan Recognized as Infection Prevention ... - University of Connecticut

Marburg virus disease